Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study

NCT03120533 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Scleroderma, Systemic

Interventions

DRUG: Iontophoresis of treprostinil
DRUG: Iontophoresis of placebo

Sponsor

University Hospital, Grenoble

Collaborators

[object Object]
[object Object]